Overview

Investigation of Neural Stem Cells in Ischemic Stroke

Status:
Terminated
Trial end date:
2021-03-02
Target enrollment:
Participant gender:
Summary
A study of stereotactic, intracerebral injection of CTX0E03 neural stem cells into patients with moderate to moderately severe disability as a result of an ischemic stroke.
Phase:
Phase 2
Details
Lead Sponsor:
ReNeuron Limited